Constance Farley

1.6k total citations
19 papers, 1.2k citations indexed

About

Constance Farley is a scholar working on Surgery, Endocrine and Autonomic Systems and Physiology. According to data from OpenAlex, Constance Farley has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Endocrine and Autonomic Systems and 5 papers in Physiology. Recurrent topics in Constance Farley's work include Cholesterol and Lipid Metabolism (7 papers), Regulation of Appetite and Obesity (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Constance Farley is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Regulation of Appetite and Obesity (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Constance Farley collaborates with scholars based in United States, United Kingdom and Japan. Constance Farley's co-authors include Margaret van Heek, Harry R. Davis, Lizbeth Hoos, John A. Cook, Douglas S. Compton, Timothy J. Kowalski, Brian D. Spar, Joyce Hwa, Edmund J. Sybertz and Kevin B. Alton and has published in prestigious journals such as Diabetes, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Constance Farley

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Constance Farley United States 13 481 335 283 268 204 19 1.2k
Douglas S. Compton United Kingdom 17 1.2k 2.4× 741 2.2× 519 1.8× 498 1.9× 479 2.3× 24 2.5k
Margaret van Heek United States 21 953 2.0× 887 2.6× 527 1.9× 684 2.6× 621 3.0× 40 2.7k
Elisabeth Christiansen Denmark 21 512 1.1× 105 0.3× 1.0k 3.6× 290 1.1× 259 1.3× 28 1.6k
Bharat Shimpukade Denmark 12 296 0.6× 60 0.2× 559 2.0× 186 0.7× 195 1.0× 15 962
Anuradha S. Pappu United States 25 688 1.4× 33 0.1× 638 2.3× 266 1.0× 142 0.7× 50 1.5k
Ziro Suzuoki Japan 13 232 0.5× 103 0.3× 482 1.7× 345 1.3× 101 0.5× 45 1.1k
Susanne Bennett Clark United States 24 457 1.0× 41 0.1× 412 1.5× 282 1.1× 356 1.7× 41 1.3k
Lianxia Guo China 17 69 0.1× 450 1.3× 346 1.2× 298 1.1× 44 0.2× 35 1.0k
Karla Carvajal Mexico 19 102 0.2× 58 0.2× 553 2.0× 340 1.3× 82 0.4× 46 1.2k
Nianning Qi United States 7 119 0.2× 93 0.3× 433 1.5× 377 1.4× 69 0.3× 8 1.2k

Countries citing papers authored by Constance Farley

Since Specialization
Citations

This map shows the geographic impact of Constance Farley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Farley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Farley more than expected).

Fields of papers citing papers by Constance Farley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Farley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Farley. The network helps show where Constance Farley may publish in the future.

Co-authorship network of co-authors of Constance Farley

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Farley. A scholar is included among the top collaborators of Constance Farley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Farley. Constance Farley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Deng, Yongqi, Zhiwei Yang, Gerald W. Shipps, et al.. (2012). Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Bioorganic & Medicinal Chemistry Letters. 23(3). 791–796. 15 indexed citations
2.
Li, Guo‐Qing, Andrew W. Stamford, Ying Huang, et al.. (2007). Discovery of novel orally active ureido NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(3). 1146–1150. 14 indexed citations
3.
Kowalski, Timothy J., Brian D. Spar, Blair Weig, et al.. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. European Journal of Pharmacology. 535(1-3). 182–191. 44 indexed citations
4.
McBriar, Mark D., Henry Guzik, Sherry Shapiro, et al.. (2006). Discovery of Orally Efficacious Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Agents. Synthesis, SAR, and Biological Evaluation of Bicyclo[3.1.0]hexyl Ureas. Journal of Medicinal Chemistry. 49(7). 2294–2310. 58 indexed citations
5.
Kowalski, Timothy J., Brian D. Spar, Mandy J. Maguire, et al.. (2005). Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. Journal of Endocrinology. 185(1). 151–164. 59 indexed citations
6.
Palani, Anandan, Sherry Shapiro, Mark D. McBriar, et al.. (2005). Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity. Journal of Medicinal Chemistry. 48(15). 4746–4749. 54 indexed citations
7.
Kowalski, Timothy J., Constance Farley, Mary Cohen-Williams, Geoffrey B. Varty, & Brian D. Spar. (2004). Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size. European Journal of Pharmacology. 497(1). 41–47. 68 indexed citations
8.
Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2003). Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats. British Journal of Pharmacology. 138(8). 1459–1464. 51 indexed citations
9.
Farley, Constance, et al.. (2003). Meal Pattern Analysis of Diet‐Induced Obesity in Susceptible and Resistant Rats. Obesity Research. 11(7). 845–851. 146 indexed citations
10.
Ghibaudi, Lorraine, John A. Cook, Constance Farley, Margaret van Heek, & Joyce Hwa. (2002). Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague‐Dawley Rats. Obesity Research. 10(9). 956–963. 169 indexed citations
11.
Heek, Margaret van, Constance Farley, Douglas S. Compton, Lizbeth Hoos, & Harry R. Davis. (2001). Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. British Journal of Pharmacology. 134(2). 409–417. 173 indexed citations
12.
Heek, Margaret van, et al.. (2001). Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Normalizes Combined Dyslipidemia in Obese Hyperinsulinemic Hamsters. Diabetes. 50(6). 1330–1335. 71 indexed citations
13.
Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2000). Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. British Journal of Pharmacology. 129(8). 1748–1754. 265 indexed citations
14.
Heek, Margaret van, Constance Farley, Douglas S. Compton, et al.. (2000). The potent cholesterol absorption inhibitor, ezetimibe, is glucuronidated in the intestine, localizes to the intestine, and circulates enterohepatically. Atherosclerosis. 151(1). 155–155. 9 indexed citations
15.
16.
Heek, Margaret van, Constance Farley, Douglas S. Compton, Lizbeth Hoos, & Harry R. Davis. (2000). The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function. Atherosclerosis. 151(1). 155–155. 6 indexed citations
17.
Handley, Dean A., et al.. (1989). Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity.. PubMed. 19. 367–70. 1 indexed citations
18.
Handley, Dean A., Constance Farley, Richard Deacon, & Robert N. Saunders. (1986). Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig. Prostaglandins Leukotrienes and Medicine. 21(3). 269–277. 12 indexed citations
19.
Winslow, Christine M., et al.. (1985). Inhibition of platelet activating factor: Synthesis and biological activity of SRI 63-073, a new phospholipid PAF-acether antagonist. Prostaglandins. 30(4). 690–690. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas S. Compton Breakdown of academic impact, for papers by Margaret van Heek Breakdown of academic impact, for papers by Elisabeth Christiansen Breakdown of academic impact, for papers by Bharat Shimpukade Breakdown of academic impact, for papers by Anuradha S. Pappu Breakdown of academic impact, for papers by Ziro Suzuoki Breakdown of academic impact, for papers by Susanne Bennett Clark Breakdown of academic impact, for papers by Lianxia Guo Breakdown of academic impact, for papers by Karla Carvajal Breakdown of academic impact, for papers by Nianning Qi
Rankless by CCL
2026